Axsome Therapeutics, Inc.

AXSM

$207.25

-0.53%

2026-09-04 11:00:14 EDT-$1.10

Healthcare

Biotechnology

NASDAQ

Active Trading

Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for a range of central nervous system (CNS) ...

Key Products & Solutions of AXSM

No product data available

Supply Chain of AXSM

Upstream / Downstream / Proxies

Upstream

Contract Manufacturing Organizations (CMOs — small molecule oral solid dose)Active Pharmaceutical Ingredient (API) Suppliers — Dextromethorphan HBr, Bupropion HCl, Solriamfetol, Meloxicam, RizatriptanJazz Pharmaceuticals plc (legacy Sunosi supply chain)NASDAQ:JAZZ Pfizer Inc.NYSE:PFEAntecip Bioventures II LLCThird-Party Logistics Providers (3PLs)Excipient & Packaging Material Suppliers

Downstream

Cencora, Inc. (formerly AmerisourceBergen)NYSE:COR Cardinal Health, Inc.NYSE:CAH McKesson CorporationNYSE:MCKPharmanoviaGroup Purchasing Organizations (GPOs)Teva Pharmaceutical Industries Ltd.NYSE:TEVASpecialty & Retail Pharmacies (CVS, Walgreens, Rite Aid, independent pharmacies)

Proxies

Jazz Pharmaceuticals plcNASDAQ:JAZZ Harmony Biosciences Holdings, Inc.NASDAQ:HRMY Sage Therapeutics, Inc.NASDAQ:SAGE Catalent, Inc.NYSE:CTLT Thermo Fisher Scientific Inc.NYSE:TMO

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer